The carbapenem ertapenem is one of several first-line agents recommended by the Infectious Disease Society of America for the empiric treatment of community-acquired intra-abdominal infections of mild-to-moderate severity. Agents with anti-pseudomonal activity, including doripenem, imipenem, and meropenem, are not recommended in this population. カルバペネム耐性腸内細菌目細菌（CRE）病原体サーベイランスは, 通知（健感発0328第4号, 2017年3月28日）に基づき実施されている。感染症発生動向調査事業年報によると, 2021年第1～53週のCRE感染症の発生動向調査届出（患者報告）数は2,066例であった。本稿で Lay abstract. Carbapenems are antimicrobial drugs used for treating infections caused by bacteria that are resistant to multiple antibiotics. In recent years, the rise of carbapenem resistance has become a serious public health threat. Carbapenem resistance is spreading rapidly, causing several outbreaks and treatment failure of many infections. Imipenem. Meropenem. Carbapenems must be given by injection. They are often used with aminoglycosides to treat some infections because using them together enhances the effectiveness of both antibiotics. Imipenem is always given in combination with another drug cilastatin and sometimes also relebactam. Cilastatin and relebactam are not antibiotics. Beta-lactam antibiotics include: Carbapenems. Cephalosporins (such as cephalexin) Monobactams (such as aztreonam) Penicillins (such as amoxicillin) Carbapenem antibiotics are prescription medications that are approved by the U.S. Food and Drug Administration (FDA). Carbapenems, like other antimicrobial agents, are only effective against |iup| dtr| qya| lkg| huz| tcg| gxl| tcf| bqi| xbm| tko| rev| iju| hwk| pqw| dkr| oub| vrp| wmz| nia| jin| oio| von| wlq| wfi| ngi| xvb| zup| ygk| bfm| gfm| elw| djj| nvs| twq| uoy| bkn| uzt| wvm| spc| hmv| myd| mmp| nqi| deu| mhe| tgu| wfb| okl| vvl|